Seer to Report First Quarter 2026 Financial Results on May 13, 2026
Rhea-AI Summary
Seer (Nasdaq: SEER) will report first-quarter 2026 financial results on May 13, 2026. Management will host a live webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET. Live audio will be on the Investor section of Seer's website and an archived replay will follow.
Positive
- None.
Negative
- None.
News Market Reaction – SEER
In the Apr 30 session, SEER gained 3.72%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Earnings date set | Neutral | +2.3% | Announced date and webcast details for Q4 and full-year 2025 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited history shows a modestly positive move (+2.29%) on the last earnings-date announcement.
Recent news for SEER has centered on an activist acquisition proposal and strategic collaborations, with notable price moves around the Radoff-JEC Group’s bids in April 2026. For earnings-date specific history, SEER previously announced Q4 and full-year 2025 results timing on Feb 5, 2026, which saw a +2.29% move over 24 hours. Today’s announcement similarly schedules the upcoming Q1 2026 results and webcast details.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced analytical software. Seer's products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Contact:
Marissa Bych
investor@seer.bio